Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017102
The University of Chicago
Search grants from The University of Chicago
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Analysis of Quantitative High Throughput Screening Data
Therapeutic targeting of Src kinase signal transduction pathways in AML
Healthy Hearts Across Generations
Core - Plant
Regulation of Neuronal Mitosis
Recently added grants:
A phase 0 pilot study to determine if papaverine increases oxygenation in spontaneous canine soft tissue sarcoma
Optimization and Validation of an indicator cell assay for blood-based diagnosis of lung cancer
HIV Vaccines Clinical Trials Network Leadership and Operations Center
Genomics of PTSD and Related Traits
Mechanical stress reprograms mitochondrial metabolism to support tumor survival and invasion through the mitochondrial unfolded protein response
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017102-013
Application #
7191420
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
The University of Chicago
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
Comments
Be the first to comment on this grant